WTBOA Topper Gives Sir Prancealot Another Del Mar 2YO Winner

4th-Del Mar, $84,000, (S), Msw, 8-10, 2yo, 5fT, :58.49, fm, 3 3/4 lengths.
IMPEACHALOT (c, 2, Sir Prancealot {Ire}–Impeached {SP, $174,497}, by Northern Afleet) became the second North American-sired 2-year-old winner for his sire (by Tamayuz {GB}) with a daylight success on debut. Of at 21-5, the bay–blinkered equipped with a shadow roll for this first go–chased from second around the turn and into the stretch, had a look at the grandstand while making the lead about a furlong from home and went farther clear while being kept to his task late. A half-brother to Slack Tide (Shaman Ghost), MSW, $141,640. Impeachalot was the $85,000 topper at the 2022 WTBOA Yearling Sale as his consignor Terry and Mary Lou Griffin's Griffin Place dominated among the sellers. The yearling half-brother by Outwork is set to be offered by Griffin Place at this year's sale Aug. 22. It was announced last week that Sir Prancealot would no longer be shuttling to Australia and would remain permanently at Rancho San Miguel in California. Sales history: $85,000 Ylg '22 WASSEP. Lifetime Record: 1-1-0-0, $49,200. Click for the Equibase.com chart or VIDEO, sponsored by FanDuel TV.
O-Philip Lebherz & Richard Meister; B-William T Griffin (KY); T-Brian J Koriner.

 

 

 

The post WTBOA Topper Gives Sir Prancealot Another Del Mar 2YO Winner appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Research Proposals on Lasix will be Accepted by HISA Sept. 1

The Horseracing Integrity and Safety Authority called for potential researchers to prepare research proposals on the administration of furosemide, still commonly called Lasix in racing, to Thoroughbred racehorses during the 48-hour period before the start of a race, the organization said in a release Thursday evening. The call for proposals is expected to be released Sept. 1.

As the Authority was created by the Horseracing Integrity and Safety Act (HISA) of 2020, it is mandated by Congress to include at least one study on the use of furosemide. Included in the study is the effect of Lasix on equine health and the integrity of competition while using the medication.

Study conclusions will be used to guide the Authority's Furosemide Advisory Committee (FAC) in its recommendations to the Authority's Board. In evaluating applications, the FAC will pay particular attention to the impact of the proposed work as it applies to racing in North America.

Any questions should be directed to feedback@hisaus.org and titled “HISA research.”

The post Research Proposals on Lasix will be Accepted by HISA Sept. 1 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights